This Week in Nature

In this week's Nature, an international team of researchers reports a new CRISPR/Cas9-based approach for the targeted integration of transgenes in dividing and non-dividing cells, both in vitro and in vivo. The homology-independent targeted integration (HITI) strategy is expected to help advance basic and translational neuroscience research, according to the investigators, who demonstrated its applicability by improving visual function in rats.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.